MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, Neoplasia Contractor Advisory Committee Meeting: September 4, 2025

Published 08/25/2025

Palmetto GBA, CGS Administrators, Noridian Healthcare Solutions and WPS Government Health Administrators will host a Multi-Jurisdictional Contractor Advisory Committee (CAC) Meeting via Microsoft Teams Webinar on September 4, 2025, from 2–4 p.m. ET. Discussions will focus on MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, Neoplasia.

The Centers for Medicare & Medicaid Services (CMS) assigned Medicare Administrative Contractors (MACs) the task of developing Local Coverage Determinations (LCDs). The purpose of the CAC meeting is to provide a formal mechanism for healthcare professionals to be informed of the evidence used in developing an LCD and promote communications between the MACs and the healthcare community. The CAC panel will discuss the clinical literature related to MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, Neoplasia and rate their confidence in a series of Key Questions. Discussions will occur between CAC panelists and Contractor Medical Directors. The public may attend; however, questions from the public will not be entertained. 

Interested stakeholders are invited to listen via Microsoft Teams Webinar; however, advance registration is required. Please Register Here to attend this MoIDX CAC Meeting .You will receive your confirmation email once you complete registration.

Note: Registration deadline is Wednesday, September 3, 2025, 11:59 p.m. ET.

Lines will remain muted throughout the conference except for the invited CAC panelists and the MAC hosts.

Meeting Materials

Microsoft Teams Webinar

Conference Title: Palmetto GBA MolDX Multi-Jurisdictional CAC Meeting

Conference Date: Thursday, September 4, 2025

Conference Time: 2–4 p.m. ET

Meeting ID: 280 700 577 471 4

Passcode: DL22E5et

Link: Join the meeting

Conference Dial-In Number: (803) 393–7908

Phone Conference ID: 901 563 716 #


Was this article helpful?